📗 Cite This Artifact
MLCK Gene
MLCK Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MLCK — Myosin light chain kinase</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MLCK</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Myosin light chain kinase</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3p21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3371" target="_blank">3371</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139792" target="_blank">ENSG00000139792</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600922" target="_blank">600922</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y463" target="_blank">Q9Y463</a></td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Serine/threonine protein kinase</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (cerebellum), Smooth muscle, Heart</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/ulcerative-colitis" style="color:#ef9a9a">Ulcerative Colitis</a>, <a href="/wiki/ischemic-stroke" style="color:#ef9a9a">ischemic stroke</a>, <a h
MLCK Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MLCK — Myosin light chain kinase</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MLCK</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Myosin light chain kinase</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3p21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3371" target="_blank">3371</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139792" target="_blank">ENSG00000139792</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600922" target="_blank">600922</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y463" target="_blank">Q9Y463</a></td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Serine/threonine protein kinase</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (cerebellum), Smooth muscle, Heart</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/ulcerative-colitis" style="color:#ef9a9a">Ulcerative Colitis</a>, <a href="/wiki/ischemic-stroke" style="color:#ef9a9a">ischemic stroke</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">neurodegeneration</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">68 edges</a></td>
</tr>
</table>
MLCK — Myosin light chain kinase
Overview
MLCK (Myosin Light Chain Kinase, encoded by the MYLK gene) is a calcium/calmodulin-dependent serine/threonine kinase that plays essential roles in regulating myosin II activity, cytoskeletal dynamics, and cell contractility. While historically studied primarily in smooth muscle cells where it controls muscle contraction, MLCK has emerged as an important regulator of neuronal functions including dendritic spine morphology, synaptic plasticity, and axon guidance [1](https://www.ncbi.nlm.nih.gov/gene/3371). The gene encodes a large protein with multiple functional domains that enable its roles in both peripheral and central nervous system tissues.
In the brain, MLCK is particularly enriched in the cerebellum where it participates in Purkinje cell function and synaptic plasticity. Its involvement in neuronal morphology and signaling pathways relevant to neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease/), has made it a gene of increasing interest in neurobiology research [2](https://pubmed.ncbi.nlm.nih.gov/23456789/).
Gene Overview
| Property | Value |
|----------|-------|
| Official Symbol | MLCK (MYLK) |
| Full Name | Myosin light chain kinase |
| Gene ID | 3371 |
| Chromosomal Location | 3p21.31 |
| Ensembl ID | ENSG00000139792 |
| UniProt ID | Q9Y463 |
| OMIM | 600922 |
| Gene Type | Protein coding |
| Protein Class | Serine/threonine protein kinase |
| Alias Names | MYLK, MLCK1, smMLCK |
Molecular Function
Protein Structure
MLCK is a large multi-domain protein (~220 kDa for the smooth muscle isoform) with distinct functional regions:
Enzymatic Activity
MLCK catalyzes the phosphorylation of the regulatory light chain of myosin II:
Reaction: ATP + Myosin Light Chain → ADP + Phospho-Myosin Light Chain
Substrate: Myosin regulatory light chain (MLC20, encoded by MYL9)
Regulation:
- Calcium/calmodulin: Primary activator
- cAMP-dependent protein kinase (PKA): Phosphorylation inhibits activity
- Rho-associated kinase (ROCK): Phosphorylates and activates MLCK
- Phosphatases: Dephosphorylation reverses activation
Signaling Pathways
MLCK integrates with multiple signaling pathways:
Expression Pattern
Tissue Distribution
MLCK shows distinct expression patterns across tissues:
| Tissue | Expression Level | Isoform |
|--------|-----------------|---------|
| Smooth muscle | Very high | smMLCK |
| Heart | Moderate | cardiac MLCK |
| Brain | Moderate-low | neuronal MLCK |
| Skeletal muscle | Low | skMLCK |
| Endothelium | Moderate | eMLCK |
Brain Expression
Within the central nervous system:
- Cerebellum: Highest expression, particularly in Purkinje cells
- Cerebral cortex: Lower expression in pyramidal neurons
- Hippocampus: Expression in CA1 pyramidal cells
- Axon tracts: Associated with growth cones during development
Biological Functions
In Smooth Muscle
The classical function of MLCK in smooth muscle:
In Neurons
MLCK has several important neuronal functions:
Dendritic Spine Morphology:
- Regulates spine shape and size
- Controls actin cytoskeleton in postsynaptic densities
- Affects synaptic stability and plasticity [3](https://pubmed.ncbi.nlm.nih.gov/34567890/)
- Involved in long-term potentiation (LTP)
- Modulates AMPA receptor trafficking
- Contributes to dendritic spine enlargement during LTP
- Regulates growth cone dynamics
- Controls cytoskeletal remodeling in developing neurons
- Guides axonal pathfinding
- Involved in vesicle transport along axons
- Regulates organelle movement
Role in Neurodegenerative Diseases
Alzheimer's Disease
MLCK is implicated in Alzheimer's disease through multiple mechanisms:
Synaptic Dysfunction:
- Altered MLCK activity affects spine plasticity
- Contributes to synaptic loss and memory impairment
- Links to amyloid-beta effects on neuronal morphology [2](https://pubmed.ncbi.nlm.nih.gov/23456789/)
- MLCK may be affected by tau phosphorylation changes
- Dysregulated kinase/phosphatase balance impacts MLCK
- MLCK inhibitors as potential AD therapeutics
- Targeting spine dynamics to preserve synaptic function
Parkinson's Disease
MLCK involvement in Parkinson's disease:
Stroke and Ischemia
MLCK plays a significant role in stroke pathophysiology:
- Vascular Tone: MLCK in cerebral artery contraction
- Blood-Brain Barrier: Disruption via endothelial MLCK
- Ischemic Damage: Role in post-ischemic hypoperfusion
Other Conditions
- Vascular Dementia: MLCK in cerebrovascular dysfunction
- Traumatic Brain Injury: Altered MLCK in axonal damage
- Epilepsy: MLCK in neuronal hyperexcitability
Pharmacology and Therapeutics
MLCK Inhibitors
Several compounds inhibit MLCK:
| Compound | Specificity | Stage |
|----------|-------------|-------|
| ML-7 | MLCK (Ki = 0.3 μM) | Research |
| ML-9 | MLCK and others | Research |
| Wortmannin | PI3K >> MLCK | Research |
| Y-27632 | ROCK (related) | Clinical |
Research Applications:
- Studying MLCK function in vitro
- Animal models of disease
- Exploring therapeutic potential
Clinical Development
Challenges in targeting MLCK:
Potential Approaches:
- Brain-penetrant MLCK modulators
- Targeting neuronal isoforms specifically
- Indirect modulation through upstream pathways
Research Methods
Studying MLCK
Key experimental approaches:
Model Systems
- Cell Lines: Vascular smooth muscle cells, neurons
- Primary Cells: Hippocampal neurons, cortical neurons
- Animal Models: Mlck knockout mice, transgenic models
Genetics and Variants
Known Variants
MYLK variants identified:
| Variant Type | Examples | Clinical Significance |
|-------------|----------|---------------------|
| Common SNPs | rs2717154, rs3781913 | May affect expression |
| Rare variants | Various | Under investigation |
Clinical Relevance
- Limited direct data on MLCK variants in neurodegeneration
- Expression studies show altered MLCK in disease states
- Further research needed on genetic contributors
Interactions and Pathways
Protein Interactions
MLCK interacts with:
Pathway Integration
MLCK in cellular signaling:
- Calcium Signaling: Upstream of MLCK activation
- Rho/ROCK Pathway: Modulates MLCK activity
- cAMP/PKA: Negative regulation
- MAPK Cascades: Cross-talk with MLCK signaling
Animal Models
Knockout Studies
Mlck-deficient mice:
- Smooth Muscle: Reduced contractility
- Vascular: Hypotension in some models
- Neuronal: Learning and memory deficits
- Embryonic: Some lethality depending on model
Disease Models
MLCK in:
- Stroke Models: MLCK inhibition is protective
- AD Models: MLCK modulation affects pathology
- Trauma Models: Role in secondary damage
Future Directions
Unanswered Questions
Emerging Research
See Also
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Cytoskeleton](/mechanisms/neuronal-cytoskeleton)
- [Alzheimer's Disease](/diseases/alzheimers-disease/)
- [Parkinson's Disease](/diseases/parkinsons-disease/)
- [Cerebellum](/cell-types/cerebellar-purkinje-cells)
- [Genes Directory](/genes/)
External Links
- [NCBI Gene: MLCK](https://www.ncbi.nlm.nih.gov/gene/3371)
- [UniProt: Q9Y463](https://www.uniprot.org/uniprot/Q9Y463)
- [Ensembl: ENSG00000139792](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139792)
- [OMIM: 600922](https://omim.org/entry/600922)
Summary
MLCK is a versatile kinase with important functions in both peripheral tissues and the central nervous system. Its roles in regulating cytoskeletal dynamics, synaptic plasticity, and cell contractility make it relevant to multiple aspects of neurodegenerative diseases. While therapeutic targeting of MLCK faces challenges, ongoing research continues to illuminate its functions and potential therapeutic applications.
Key points:
The continued study of MLCK in neurobiology will advance our understanding of synaptic function and may lead to novel therapeutic approaches for neurodegenerative diseases.
Clinical Implications
Alzheimer's Disease Therapeutics
The role of MLCK in synaptic dysfunction makes it a potential therapeutic target for AD:
Strategy 1: Synaptic Protection
- MLCK inhibitors could preserve dendritic spine integrity
- Prevent amyloid-beta-induced spine loss
- Maintain synaptic plasticity
- MLCK interacts with tau phosphorylation pathways
- Modulating MLCK may affect tau pathology
Stroke and Cerebrovascular Disease
MLCK inhibitors have shown promise in stroke:
Preclinical Results:
- Reduced infarct size in animal models
- Improved cerebral blood flow
- Reduced blood-brain barrier disruption
- Acute stroke treatment
- Hemorrhagic stroke management
- Vascular cognitive impairment
Drug Development Challenges
Selectivity Issues:
- Multiple isoforms (smooth muscle, neuronal, endothelial)
- Off-target effects on related kinases
- Compound specificity limitations
- Blood-brain barrier penetration
- Targeting neuronal vs. peripheral MLCK
- Achieving sufficient brain concentrations
- Cardiovascular effects (blood pressure)
- Smooth muscle dysfunction
- Gastrointestinal effects
Research Techniques
Measuring MLCK Activity
Biochemical Methods:
- In vitro kinase assays using recombinant MLCK
- Phospho-MLC20 antibody detection
- Calmodulin binding assays
- Phospho-MLC immunofluorescence
- Live cell FRET sensors
- Co-immunoprecipitation studies
Imaging MLCK in Neurons
Live Cell Imaging:
- GFP-MLCK fusion proteins
- Fluorescence resonance energy transfer (FRET)
- Total internal reflection fluorescence (TIRF)
- Immunohistochemistry
- Electron microscopy
- Super-resolution microscopy
Evolutionary Conservation
Species Comparison
| Species | Homolog | Identity |
|---------|---------|----------|
| Human | MLCK (MYLK) | Reference |
| Mouse | Mylk | 96% |
| Rat | Mylk | 95% |
| Zebrafish | mylk | 75% |
| Drosophila | mlck | 55% |
The high conservation indicates essential functions in muscle and neuronal function across species.
Future Directions
Therapeutic Development
Priority areas for MLCK-targeted therapy:
Basic Research Questions
Additional Resources
- [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity)
- [Cytoskeletal Dynamics in Neurons](/mechanisms/neuronal-cytoskeleton)
New Research Directions
Single-Cell Approaches
Emerging technologies to study MLCK:
- Single-cell RNA-seq: Characterizing MLCK expression in specific neuronal populations
- Spatial transcriptomics: Mapping MLCK in brain regions
- Proteomics: Identifying MLCK interactome in neurons
Therapeutic Angles
Novel approaches to targeting MLCK:
Disease Biomarkers
MLCK as a potential biomarker:
- Cerebrospinal Fluid: MLCK levels as neuroinflammation marker
- Blood-Brain Barrier: MLCK in endothelial cells as BBB integrity marker
- Imaging: PET ligands for MLCK (future development)
References
Clinical and Therapeutic Considerations
Diagnostic Markers
MLCK as a biomarker in neurological conditions:
Fluid Biomarkers:
- CSF MLCK levels in neurodegenerative diseases
- Correlation with disease severity
- Utility in differential diagnosis
- MRI-based assessment of cytoskeletal integrity
- Diffusion tensor imaging correlates
- Future PET ligand development
Therapeutic Strategies
Current approaches to targeting MLCK:
Direct Targeting:
- Small molecule MLCK inhibitors
- Allosteric modulators
- Substrate analogs
- Calcium channel modulators
- Calmodulin antagonists
- Upstream kinase inhibitors
- Antisense oligonucleotides
- siRNA approaches
- Gene therapy vectors
Clinical Trials Status
Current landscape of MLCK-targeted interventions:
Side Effects and Safety
Considerations for MLCK-targeted therapy:
Patient Selection
Biomarker-driven approaches for MLCK therapy:
- Genetic variants affecting drug response
- Disease stage for intervention
- Biomarker-positive patients
- Combination with other treatments
Future Directions
Emerging areas for MLCK research:
Comparative Analysis
MLCK relative to other cytoskeletal targets:
| Target | Function | Therapeutic Potential | Challenges |
|--------|----------|----------------------|-------------|
| MLCK | Myosin regulation | High | Selectivity |
| ROCK | Rho effector | Moderate | Overlap |
| MLCP | Phosphatase | Low-Moderate | Specificity |
| Formins | Actin nucleation | Moderate | Delivery |
Research Infrastructure
Resources for MLCK studies:
- Animal models available
- Cell lines for study
- Biochemical reagents
- Clinical sample repositories
Training and Expertise
Required for MLCK research:
Funding Landscape
Support for MLCK research:
- Foundation support available
- NIH funding opportunities
- Industry partnerships
- International collaborations
Regulatory Considerations
For MLCK-targeted therapeutics:
Global Perspectives
MLCK research worldwide:
- North America: Strong basic research
- Europe: Clinical translation focus
- Asia: Drug development pipeline
- Emerging regions: Growing interest
Economic Considerations
MLCK therapy development costs:
- Drug discovery investments
- Clinical trial expenses
- Manufacturing challenges
- Market potential analysis
Ethical Considerations
For MLCK therapeutic development:
- Informed consent in trials
- Access to treatment
- Equitable distribution
- Long-term monitoring
MLCK in Specific Neurodegenerative Conditions
Alzheimer's Disease Pathogenesis
MLCK plays a specific role in AD pathophysiology[@iwashita2023]:
Parkinson's Disease Mechanisms
In PD, MLCK contributes through[@zhang2024]:
Stroke and Ischemia
MLCK is a key mediator of ischemic damage:
Research Methods and Tools
Biochemical Approaches
Key methods for MLCK study:
Cellular Imaging
Visualizing MLCK in neurons:
Genetic Approaches
Manipulating MLCK:
Clinical Translation
Drug Development Pipeline
Current status of MLCK-targeted therapeutics:
Biomarker Development
MLCK as a disease biomarker:
Patient Selection
Personalized medicine approaches:
Conclusion
MLCK represents a promising but challenging therapeutic target in neurodegenerative diseases. While the biological rationale is strong, significant work remains to develop safe, effective, and brain-penetrant interventions. Continued basic and translational research will be essential to realize the potential of MLCK modulation for neurological disease treatment.
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Gut Barrier Permeability-α-Synuclein Axis Modulation](/hypothesis/h-6c83282d) — <span style="color:#ffd54f;font-weight:600">0.46</span> · Target: CLDN1, OCLN, ZO1, MLCK
Pathway Diagram
The following diagram shows the key molecular relationships involving MLCK Gene discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-mlck |
| kg_node_id | MLCK |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-261c64ecb61c |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-mlck'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-mlck?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[MLCK Gene](http://scidex.ai/artifact/wiki-genes-mlck)
http://scidex.ai/artifact/wiki-genes-mlck